0001209191-13-042970.txt : 20130904 0001209191-13-042970.hdr.sgml : 20130904 20130904165126 ACCESSION NUMBER: 0001209191-13-042970 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130903 FILED AS OF DATE: 20130904 DATE AS OF CHANGE: 20130904 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SafeStitch Medical, Inc. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4400 BISCAYNE BLVD. STREET 2: SUITE A-100 CITY: MIAMI STATE: FL ZIP: 33137 BUSINESS PHONE: 305-575-4600 MAIL ADDRESS: STREET 1: 4400 BISCAYNE BLVD. STREET 2: SUITE A-100 CITY: MIAMI STATE: FL ZIP: 33137 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Starling William N JR CENTRAL INDEX KEY: 0001324130 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 131078401 MAIL ADDRESS: STREET 1: 2300 BUCKSKIN ROAD CITY: POCATELLO STATE: ID ZIP: 83201 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2013-09-03 0 0000876378 SafeStitch Medical, Inc. SFES.OB 0001324130 Starling William N JR 3284 ALPINE ROAD PORTOLA VALLEY CA 94028 1 0 0 0 Common Stock 611249 I By W. Starling, Jr., and D. Starling, Trustees of the Starling Family Trust, UDT August 15, 1990 Common Stock 23066 I By Mark Starling, Trustee of the William N. Starling, Jr. and Dana Gregory Starling 1990 Irrevocable Common Stock 1960610 I By Synecor, L.L.C. Common Stock 16825253 I By Synergy Life Science Partners, L.P. Employee Stock Option (right to buy) 0.07 2022-04-12 Common Stock 172995 D The Reporting Person is a managing member of Synecor, L.L.C ("Synecor"). The Reporting Person disclaims beneficial ownership of the shares held by Synecor except to the extent of his proportionate pecuniary interest therein. The Reporting Person is a Manager of Synergy Venture Partners, LLC which serves as the sole General Partner of Synergy Life Science Partners, LP ("Synergy"). As such, the Reporting Person shares voting and investment control over the securities owned by Synergy, and may be deemed to own beneficially the securities held by Synergy. The Reporting Person disclaims beneficial ownership of the shares held by Synergy except to the extent of this proportionate pecuniary interest therein. This option vests and the shares become exercisable according to the following schedule: 1/48 per month beginning on April 12, 2012. /s/ William N. Starling, Jr. 2013-09-03